OBJECTIVE: To describe the incidence of the catheter-related local infection (CRLI) and catheter-related bloodstream infection (CRBSI) of central venous catheters (CVCs) and arterial catheters (ACs). DESIGN: Prospective, observational study. SETTING: A 24-bed medical-surgical intensive care unit of a 650-bed university hospital. PATIENTS: We included 988 consecutive patients admitted to the ICU during 18 months. MEASUREMENTS: The incidence density of CRLI and CRBSI, per 1000 catheter-days, of CVC and AC. RESULTS: Central venous catheters had a significantly higher incidence density of CRLI (4.74 vs 0.97/1,000 catheter-days; p<0.001) than ACs. Femoral venous access had a higher incidence density of CRLI than subclavian (13.15 vs 1.81/1,000 catheter-days, p=0.003) and than peripheral access (13.15 vs 2.30/1,000 catheter-days, p<0.001). Jugular venous access had a higher incidence density of CRLI (6.29 vs 1.81/1,000 catheter-days, p<0.001) than subclavian access. We found no significant differences in the incidence density of CRLI and CRBSI between the different AC accesses. CONCLUSIONS: In the CDC guidelines, catheter insertion at the subclavian site is recommended in preference to femoral and jugular accesses, and there is no recommendation about AC site insertion. Our data support these recommendations about CVCs. Because the AC infection rate was very low, our study suggests that the access site is probably not of major importance for this type of catheter.
OBJECTIVE: To describe the incidence of the catheter-related local infection (CRLI) and catheter-related bloodstream infection (CRBSI) of central venous catheters (CVCs) and arterial catheters (ACs). DESIGN: Prospective, observational study. SETTING: A 24-bed medical-surgical intensive care unit of a 650-bed university hospital. PATIENTS: We included 988 consecutive patients admitted to the ICU during 18 months. MEASUREMENTS: The incidence density of CRLI and CRBSI, per 1000 catheter-days, of CVC and AC. RESULTS: Central venous catheters had a significantly higher incidence density of CRLI (4.74 vs 0.97/1,000 catheter-days; p<0.001) than ACs. Femoral venous access had a higher incidence density of CRLI than subclavian (13.15 vs 1.81/1,000 catheter-days, p=0.003) and than peripheral access (13.15 vs 2.30/1,000 catheter-days, p<0.001). Jugular venous access had a higher incidence density of CRLI (6.29 vs 1.81/1,000 catheter-days, p<0.001) than subclavian access. We found no significant differences in the incidence density of CRLI and CRBSI between the different AC accesses. CONCLUSIONS: In the CDC guidelines, catheter insertion at the subclavian site is recommended in preference to femoral and jugular accesses, and there is no recommendation about AC site insertion. Our data support these recommendations about CVCs. Because the AC infection rate was very low, our study suggests that the access site is probably not of major importance for this type of catheter.
Authors: H Richet; B Hubert; G Nitemberg; A Andremont; A Buu-Hoi; P Ourbak; C Galicier; M Veron; A Boisivon; A M Bouvier Journal: J Clin Microbiol Date: 1990-11 Impact factor: 5.948
Authors: J Merrer; B De Jonghe; F Golliot; J Y Lefrant; B Raffy; E Barre; J P Rigaud; D Casciani; B Misset; C Bosquet; H Outin; C Brun-Buisson; G Nitenberg Journal: JAMA Date: 2001-08-08 Impact factor: 56.272
Authors: Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein Journal: MMWR Recomm Rep Date: 2002-08-09
Authors: J Damen; J Verhoef; D T Bolton; N G Middleton; I van der Tweel; K de Jonge; J E Wever; M Nijsen-Karelse Journal: Crit Care Med Date: 1985-07 Impact factor: 7.598
Authors: Zakary J Hambsch; Mitchell J Kerfeld; Daniel R Kirkpatrick; Dan M McEntire; Mark D Reisbig; Charles F Youngblood; Devendra K Agrawal Journal: Clin Transl Sci Date: 2015-08-14 Impact factor: 4.689
Authors: Leonardo Lorente; Alejandro Jiménez; José Luis Iribarren; Juan José Jiménez; María M Martín; María L Mora Journal: Intensive Care Med Date: 2006-06-28 Impact factor: 17.440
Authors: Leonardo Lorente; Alejandro Jiménez; Juan José Jiménez; José Luis Iribarren; María M Martín; María L Mora Journal: Intensive Care Med Date: 2006-09-22 Impact factor: 17.440
Authors: Leonardo Lorente; Alejandro Jiménez; Ramón Galván; Carolina García; Juan Castedo; María M Martín; María L Mora Journal: Intensive Care Med Date: 2007-09-21 Impact factor: 17.440
Authors: L Lorente; A Jiménez; M M Martín; J Castedo; R Galván; C García; M T Brouard; M L Mora Journal: Eur J Clin Microbiol Infect Dis Date: 2009-04-16 Impact factor: 3.267
Authors: L Lorente; A Jiménez; C García; R Galván; J Castedo; M M Martín; M L Mora Journal: Eur J Clin Microbiol Infect Dis Date: 2008-04-02 Impact factor: 3.267
Authors: Li Zhang; Kadaba S Sriprakash; David McMillan; John R Gowardman; Bharat Patel; Claire M Rickard Journal: BMC Microbiol Date: 2010-10-19 Impact factor: 3.605
Authors: Leonardo Lorente; Alejandro Jiménez; Juan Castedo; Ramón Galván; Carolina García; María M Martín; María L Mora Journal: Intensive Care Med Date: 2007-04-25 Impact factor: 17.440
Authors: Jose Garnacho-Montero; Teresa Aldabó-Pallás; Mercedes Palomar-Martínez; Jordi Vallés; Benito Almirante; Rafael Garcés; Fabrio Grill; Miquel Pujol; Cristina Arenas-Giménez; Eduard Mesalles; Ana Escoresca-Ortega; Marina de Cueto; Carlos Ortiz-Leyba Journal: Intensive Care Med Date: 2008-07-12 Impact factor: 17.440